Topic
Oncology
2stories
Oncology
Foghorn Therapeutics Cuts Staff After Eli Lilly Ends Cancer Deal
Layoffs at Foghorn Therapeutics follow Eli Lilly's exit from a cancer drug collaboration, according to Quartz…
Oct 9
Foghorn Therapeutics Cuts 40% of Staff as Lilly Walks Away
Eli Lilly's termination of its cancer collaboration with Foghorn Therapeutics triggers a 40% workforce cut an…
Oct 1
The newsroom digest
One email a day with the stories that matter. No noise.